• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE ¿ IRELAND ACUVUE OASYS 1-DAY FOR ASTIGMATISM WITH HYDRALUXE TECHNOLOGY; LENSES, SOFT CONTACT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE ¿ IRELAND ACUVUE OASYS 1-DAY FOR ASTIGMATISM WITH HYDRALUXE TECHNOLOGY; LENSES, SOFT CONTACT Back to Search Results
Catalog Number TAS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Corneal Ulcer (1796); Pain (1994); Red Eye(s) (2038); Discomfort (2330)
Event Date 08/10/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
On 01oct2019, an email was received from (b)(6) with adverse incident report reference # (b)(4).A patient (pt) in the (b)(6) was diagnosed with a corneal ulcer in the right eye (od) while wearing an unspecified acuvue brand daily disposable contact lens (cl).The pt was treated (unspecified) and made ¿good recovery,¿ but will not wear cls again until november.On (b)(6) 2019, the pt was contacted, and additional information was received.The pt confirmed wearing an acuvue® oasys® 1-day for astigmatism with hydraluxe¿ technology brand cl.On (b)(6) 2019, the pt inserted the od cl and experienced discomfort, pain, and light sensitivity by early afternoon, which worsened throughout the day.On (b)(6) 2019, the pt awoke with pain, redness, and light sensitivity in the od.The pt saw a general practitioner who advised that there was an ¿infection,¿ prescribed chloramphenicol ointment 4 times daily, and referred the pt to the hospital.On (b)(6) 2019, the pt visited the eye department of the hospital and was diagnosed with a corneal ulcer, 2mm diameter, approximately 8 o¿clock in mid-periphery.The pt was prescribed hourly levofloxacin and chloramphenicol 4 times a day.On (b)(6) 2019, the pt returned for a follow-up visit and was advised the od was healing well and to continue same treatment.At the follow-up visit on (b)(6) 2019, the pt was advised to reduce levofloxacin use.At the follow-up visit on (b)(6) 019, the pt was advised to stop all treatment and was discharged.The pt was instructed to discontinue cl wear for 3 months.The pt reported that the vision was not affected.Pt admitted to occasionally napping in cls and wearing for ¿a little too long.¿ no further information was provided.The suspect od cl was discarded.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot l003pwt was produced under normal conditions.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUVUE OASYS 1-DAY FOR ASTIGMATISM WITH HYDRALUXE TECHNOLOGY
Type of Device
LENSES, SOFT CONTACT
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE ¿ IRELAND
one technological park plassey
limerick
EI 
Manufacturer Contact
rose harrell
7500 centurion parkway
jacksonville, FL 32256
9044433364
MDR Report Key9221480
MDR Text Key169728378
Report Number9617710-2019-00037
Device Sequence Number1
Product Code LPL
Combination Product (y/n)Y
Reporter Country CodeUK
PMA/PMN Number
K042275
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,other
Reporter Occupation Other
Type of Report Initial
Report Date 10/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date09/01/2023
Device Catalogue NumberTAS
Device Lot NumberL003PWT
Was Device Available for Evaluation? No
Date Manufacturer Received10/01/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/06/2018
Is the Device Single Use? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-